cytokine-storm-analysis-agent

name	cytokine-storm-analysis-agent
description	AI-powered cytokine release syndrome (CRS) and cytokine storm analysis for prediction, monitoring, and management in immunotherapy and infectious disease.

Cytokine Storm Analysis Agent

The Cytokine Storm Analysis Agent provides comprehensive AI-driven analysis of cytokine release syndrome (CRS) and hyperinflammatory states. It integrates cytokine profiling, clinical parameters, and immunological markers for early prediction, severity grading, and treatment guidance in CAR-T therapy, sepsis, and viral infections.

When to Use This Skill

• When monitoring CAR-T patients for cytokine release syndrome risk.
• To predict CRS severity and timing post-immunotherapy.
• For analyzing cytokine panels in sepsis and viral infections (COVID-19).
• When guiding tocilizumab/siltuximab anti-IL-6 therapy decisions.
• To distinguish CRS from ICANS, HLH, and other inflammatory syndromes.

Core Capabilities

1. CRS Risk Prediction: ML models predict CRS development and severity from baseline factors (tumor burden, disease type, CAR-T product).

2. Real-Time Monitoring: Track cytokine dynamics (IL-6, IFN-γ, IL-10, ferritin) with early warning alerts.

3. Severity Grading: Automated ASTCT CRS grading using clinical parameters and biomarkers.

4. Differential Diagnosis: Distinguish CRS from HLH/MAS, ICANS, infection, and tumor lysis syndrome.

5. Treatment Guidance: AI-driven recommendations for tocilizumab, corticosteroids, and supportive care.

6. Outcome Prediction: Model response to anti-cytokine therapy and overall outcomes.

Cytokine Panel Analysis

Cytokine	Role in CRS	Kinetics	Therapeutic Target
IL-6	Central mediator	Early peak	Tocilizumab, Siltuximab
IFN-γ	T-cell activation	Early	Emapalumab
IL-1β	Inflammasome	Early	Anakinra
IL-10	Regulatory	Variable	-
TNF-α	Pro-inflammatory	Early	Infliximab (caution)
IL-2	T-cell expansion	Early	-
GM-CSF	Myeloid activation	Sustained	Lenzilumab

ASTCT CRS Grading (Automated)

Grade	Fever	Hypotension	Hypoxia
1	≥38°C	None	None
2	≥38°C	Responsive to fluids	Low-flow O2
3	≥38°C	One vasopressor	High-flow O2
4	≥38°C	Multiple vasopressors	Ventilation

Workflow

1. Input: Cytokine levels, vital signs, laboratory values, treatment history.

2. Risk Assessment: Baseline CRS risk stratification pre-therapy.

3. Monitoring: Real-time cytokine tracking with trend analysis.

4. Grading: Automated CRS grade assignment per ASTCT criteria.

5. Differential: Rule out mimics (infection, HLH, ICANS).

6. Treatment: Generate management recommendations.

7. Output: CRS risk score, grade, differential diagnosis, treatment plan.

Example Usage

User: "Monitor this CAR-T patient's cytokine levels and predict CRS severity."

Agent Action:

python3 Skills/Immunology_Vaccines/Cytokine_Storm_Analysis_Agent/crs_analyzer.py \
    --patient_data demographics.json \
    --cytokines cytokine_panel.csv \
    --vitals vital_signs.csv \
    --labs laboratory_values.csv \
    --cart_product tisagenlecleucel \
    --day_post_infusion 5 \
    --model crs_predictor_v3 \
    --output crs_report.json

AI/ML Models

CRS Risk Prediction:

• Features: tumor burden (LDH), lymphodepletion intensity, CAR-T dose, disease type
• Model: Gradient boosting with SHAP interpretability
• Performance: AUC 0.82-0.88 for severe CRS

Severity Trajectory:

• Time-series modeling of cytokine dynamics
• LSTM networks for temporal patterns
• Early warning 24-48 hours before clinical deterioration

Treatment Response:

• Tocilizumab response prediction
• Corticosteroid escalation timing
• ICU admission risk

Differential Diagnosis Decision Tree

Fever + Elevated Cytokines
          |
    CAR-T context?
    /           \
  Yes            No
   |              |
Hypotension?   Infection workup
   |              |
  CRS          Sepsis vs viral
   |
Neuro symptoms?
   |
  ICANS vs CRS
   |
Ferritin >10,000?
   |
  HLH/MAS evaluation

Clinical Decision Support

Tocilizumab Indication:

• Grade 2+ CRS
• Rapidly rising cytokines
• High-risk baseline features

Corticosteroid Indication:

• Tocilizumab-refractory CRS
• ICANS any grade
• Grade 3+ CRS

Prerequisites

• Python 3.10+
• scikit-learn, XGBoost for ML
• Time-series analysis libraries
• FHIR client for EHR integration

Related Skills

• CART_Design_Optimizer_Agent - For CAR-T design
• TCell_Exhaustion_Analysis_Agent - For T-cell function
• Clinical_NLP - For extracting symptoms from notes

Special Populations

1. Pediatric: Different baseline cytokine ranges
2. Post-COVID: Altered inflammatory responses
3. Bridging Therapy: Impact on CRS risk
4. Concurrent Infection: Confounding cytokine elevation

Author

AI Group - Biomedical AI Platform